Sort by: Latest openings
elevate.bio
elevate.bio • Pittsburgh • Health Care • Cell & Gene Therapy • 201-500 employees • Founded 2017 • Startup • New • EcoR1 Capital · MPM BioImpact • Hiring now · 5 of 13
ElevateBio is powering the industry with an integrated approach to technologies and manufacturing.
No named decision-maker yet.
Careers mailbox is known
Sep 29 Posted 5 roles, closed 1 Associate II, Biomanufacturing (Contract), Lead Specialist, QA Validation Sep 28 Closed a role Senior Manager, Metrology Sep 27 2 roles crossed 45 days open 2017 Founded
13 open +2 this week $169k stated pay, 6 roles
Board re-checked 3 hours ago · 21 events in 14 days
Follow
13 roles
···
centessa.com • Boston • Neurology & CNS Therapeutics • Prescription Drugs • 201-500 employees • Founded 2021 • Startup • New • EcoR1 Capital · Foresite Capital • Hiring now · 24 of 29
Centessa Pharmaceuticals is a transformational pharmaceutical brand that aims to discover and develop medicines that can have a profound impact on patients' lives. With an asset-centric and patient-centric approach, Centessa is committed to redefining the way medicines are made. Led by a team of leaders, innovators, and entrepreneurs, Centessa is dedicated to revolutionizing the pharmaceutical industry by bringing together the best minds in science and business. Centessa's pipeline encompasses a range of ongoing clinical trials that focus on developing groundbreaking treatments. They prioritize the expansion of patient access to these innovative therapies through their expanded access policy. Investors are also an integral part of Centessa's vision, providing support and resources to further propel their research and development efforts. With a strong emphasis on privacy and regulatory compliance, Centessa ensures that patients' confidentiality is protected and their personal information is handled with utmost care. If you want to stay updated on the latest news and career opportunities at Centessa, you can follow them on their website and social media platforms. Centessa Pharmaceu
No named decision-maker yet.
No careers mailbox known
Sep 29 Posted a role, closed 1 Associate Director, Clinical Operations (Contract) · opened in Atlanta Sep 27 Posted a role Medical Science Liaison (MSL) – South East Sep 25 Posted a role Clinical Trial Manager (Contract) 2021 Founded
29 open +4 this week closes in 57 d market 28 $203k stated pay, 28 roles
Board re-checked 6 hours ago · 20 events in 14 days
Follow
29 roles
···
omniox.com • San Carlos, United States • Startup • New • Venture round $4.7M · 10 yr ago • EcoR1 Capital · Wavemaker Three-Sixty Health
Jonathan Winger · Executive Officer, Director · decision-maker
Stephen Cary · Executive Officer, Director · decision-maker
Mitchell Mutz · Director
Laurence Marton · Director
No careers mailbox known
Jul 12, 2016 Raised a round Venture round $4.7M · SEC Form D
Follow
···
nikangtx.com • Health Care • Founded 2017 • Startup • New • EcoR1 Capital · HBM Healthcare Investments +1
Home About us Science & Pipeline News Careers About NiKang Our Company name is derived from the combination of two words "Nike" and "Kang." Nike is the Greek goddess of victory and can also mean fast, first, and strong. Kang is a Chinese word meaning good health.
No named decision-maker yet.
Careers mailbox is known
2017 Founded
Follow
···
kumquatbiosciences.com
kumquatbiosciences.com • San Diego, United States • Oncology Therapeutics • Health Care • 201-500 employees • Founded 2018 • Startup • New • Venture round $30M · 5 yr ago • EcoR1 Capital · OrbiMed
Innovating life-changing medicines for cancer patients. At Kumquat, we're on a mission to transform cancer treatment by delivering durable therapeutic benefits and a renewed sense of hope to patients.
Pingda Ren · Executive Officer · decision-maker
Yi Liu · Executive Officer, Director · decision-maker
Scott Platshon · Director
Carl Gordon · Director
Careers mailbox is known
Jul 29, 2021 Partnership Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses · kumquatbiosciences.com Jul 28, 2021 Raised a round Venture round $30M · SEC Form D 2018 Founded
Board re-checked 3 hours ago · 5 stages of its story
Follow
···
avttx.com • Mobility & Assistive Devices • Ophthalmology & Eye Clinics • Likely startup • New • A-Level Capital · EcoR1 Capital
About Us Senior Management Team Board of Directors Clinical Advisory Board Technology Pipeline Overview Migaldendranib (MGB) News Resources Careers Contact About Us Senior Management Team Jeffrey L. Cleland, Ph.D.
No named decision-maker yet.
Careers mailbox is known
Follow
···
relaytx.com
relaytx.com • Cambridge • Biotechnology • Drug Discovery • Likely startup • New • EcoR1 Capital · Nextech Invest • Hiring now · 1 of 8
Relay Therapeutics® puts protein motion at the heart of drug discovery to dramatically expand therapeutic possibilities.
No named decision-maker yet.
Careers mailbox is known
Sep 29 Closed a role Senior Manager, Drug Substance Sep 28 Clinical Project Manager crossed 90 days open Sep 26 Posted 9 roles Clinical Project Manager, VP, Head of Drug Discovery Sep 20 Manager/Senior Manager, Pharmaceutics and Drug Product crossed 45 days open
8 open +1 this week $230k stated pay, 9 roles
Board re-checked 6 hours ago · 13 events in 14 days
Follow
8 roles
···
recodetx.com
recodetx.com • Menlo Park • Health Care • Vaccines • 51-200 employees • Startup • New • EcoR1 Capital · MPM BioImpact +1
ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.
No named decision-maker yet.
Careers mailbox is known
Sep 26 Moved to Greenhouse
Board re-checked 1 day ago · 1 event in 14 days
Follow
···
terremotobio.com
terremotobio.com • Drug Discovery • Likely startup • New • EcoR1 Capital · OrbiMed
By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.
No named decision-maker yet.
Careers mailbox is known
Sep 26 Moved to Greenhouse
Board re-checked 1 day ago · 1 event in 14 days
Follow
···
flex-pharma.com
flex-pharma.com • Pharmacies • Startup • New • Venture round $40M · 12 yr ago • EcoR1 Capital · Lightstone Ventures
Optimal prices for Generic Cialis, Generic Viagra, Generic Levitra, Kamagra, Priligy as a highly impactful drugs in the context of ED therapy: reviews, precautions, and clinical indications.
No named decision-maker yet.
Careers mailbox is known
Sep 9, 2014 Raised a round Venture round $40M
Follow
···
affiniatx.com
affiniatx.com • Biotechnology • Rare Disease Therapeutics • 51-200 employees • Likely startup • New • Atlas Venture · EcoR1 Capital +2
Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines for people.
No named decision-maker yet.
Careers mailbox is known
Sep 26 Moved to Greenhouse
Follow
···